Asset Details
Do you wish to reserve the book?
Detection and Characterization of Subvisible Aggregates of Monoclonal IgG in Serum
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Detection and Characterization of Subvisible Aggregates of Monoclonal IgG in Serum
Do you wish to request the book?
Detection and Characterization of Subvisible Aggregates of Monoclonal IgG in Serum
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Detection and Characterization of Subvisible Aggregates of Monoclonal IgG in Serum
2012
Overview
Purpose
To detect and characterize the aggregation of therapeutic monoclonal antibodies in undiluted biological fluids.
Methods
Fluorescently labeled subvisible IgG aggregates formed by applying either heat stress or by pH-shift were investigated immediately after addition to human serum, and after 24 h. Unstressed and stressed IgG formulations were analyzed by fluorescence single particle tracking, confocal laser scanning microscopy and flow cytometry.
Results
Unstressed formulations remained free from subvisible aggregates in serum, whereas heat-stressed and pH-shift stressed formulations showed dissimilar aggregation behaviors. The aggregation profile of the heat-stressed formulation diluted in serum remained practically the same as the one diluted in buffer, even after the 24 h incubation period. The pH-shift stressed formulation had strikingly smaller and more numerous subvisible aggregates immediately after dilution in serum compared to buffer. These aggregates became noticeably larger in both diluents after 24 h, but in serum they appeared to be formed by other types of constituents than the labeled protein itself.
Conclusion
These results show that subvisible therapeutic protein aggregates may undergo changes in number, type and size distribution upon contact with human serum. This emphasizes the importance of analytical strategies for monitoring aggregation in undiluted biological fluids.
Publisher
Springer US,Springer,Springer Nature B.V
Subject
Antibodies, Monoclonal - blood
/ Antibodies, Monoclonal - chemistry
/ Biological and medical sciences
/ Biomedical and Life Sciences
/ Biomedical Engineering and Bioengineering
/ Fluorescent Dyes - chemistry
/ Humans
/ Immunoglobulin G - chemistry
/ Pharmaceutical technology. Pharmaceutical industry
/ Pharmacology. Drug treatments
/ Pharmacy
